1 Min Read
April 25 (Reuters) - Uniqure Nv:
* uniQure receives European Medicines Agency priority medicines (PRIME) designation for AMT-060 in Hemophilia B Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.